Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Articles tagged with "Advocates for Arthritis"

In Advocacy, Slow and Steady Wins the Race

  |  

Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

Call Your Lawmakers the Week of March 15

  |  

The elimination of consultation code services, the repeated battle to avert Medicare cuts, the need for increased research funding, the creation of a loan repayment program for pediatric rheumatologists, and fair costs for drug therapies are all issues that members of Congress have influence over. All of these issues affect the rheumatology profession, whether you are a clinical practitioner, researcher, academic, or health professional.

Don’t Just Watch Health Policy Unfold—Take Action

  |  

If you are tired of just watching and reading about health policy decisions that affect you, your patients, and your profession, take action today to help shape the future of healthcare. The ACR offers multiple ways for you to stay informed about legislation affecting rheumatology professionals and can teach you how to influence the decisions made on Capitol Hill.

Rep. Allyson Schwarz Speaks at Annual Meeting

  |  

Representative Allyson Schwarz (D-Pa.) held a Healthcare Legislative Update at the 2009 Annual Scientific Meeting in Philadelphia, held in October. Rep. Schwartz spoke to a group of rheumatology professionals about the different healthcare proposals currently before Congress. As a key member of the House Ways and Means Committee, Rep. Schwartz gave an insider’s view of the healthcare reform debate going on in the House. She was interested in the perspective of the rheumatology community and took questions from the audience. Members of the audience asked the Representative about issues important to rheumatologists, such as access to care, elimination of the sustainable growth rate formula, and medical liability reform.

I RheumPAC, Do You?

Jim Engelbrecht, MD  |  

For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

I Am an Advocate

Susan Leigh  |  

Earlier this year, I was privileged to be part of the ACR’s Advocates for Arthritis advocacy visit. My rheumatologist recommended that I apply for the event, and I was thrilled when I was accepted, even though my acceptance wasn’t necessarily competitive (I was the only patient representative from Delaware).

I Am an Advocate

Deanna Sanchez Yamamoto, NP  |  

I have never considered myself to be a political person, much less an “advocate,” which is why I was surprised to become an ARHP advocacy committee member.

I Am an Advocate

Charles King, MD  |  

It was the best of times, it was the worst of times; it was the age of wisdom, it was the age of foolishness.” Cliché perhaps, but certainly fitting in describing the practice of rheumatology of late. We have been blessed with a widening array of therapies with which to treat rheumatologic illnesses. The advent of the biological era promises even greater potential for meaningful reductions in disability and death from these diseases.